| Typicality: | 0.260 |
| Saliency: | 0.228 |
| in kidney cancer | 3 | location |
| according to researchers | 2 | other |
| vaccine → improve → progression-free survival | 7 |
| vaccine → improve → survival | 5 |
| vaccine → improve → overall survival | 4 |
| negative | neutral | positive |
| 0.009 | 0.288 | 0.702 |
| Raw frequency | 16 |
| Normalized frequency | 0.228 |
| Modifier score | 0.500 |
| Perplexity | 133.137 |